Beryl Drugs Market Cap

Beryl Drugs has a market cap or net worth of 111.32 million as of April 29, 2026. Its market cap has increased by 4.28% in one year.

Market Cap

111.32M

Enterprise Value

153.67M

Revenue

176.65M

Ranking

n/a

PE Ratio

789.53

Stock Price

23.00

Market Cap Chart

Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 111.32M, an increase of 2,913.38%. That is a compound annual growth rate of 17.71%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	111.32M	-6.20%
Dec 31, 2025	118.68M	-35.27%
Dec 31, 2024	183.34M	63.50%
Dec 29, 2023	112.14M	70.08%
Dec 30, 2022	65.93M	7.26%
Dec 31, 2021	61.47M	54.00%
Dec 31, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 26, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shamrock Industrial Company	115.99M
Ortin Global	117.91M
Colinz Laboratories	118.12M
Unjha Formulations	93.96M
Desh Rakshak Aushdhalaya	133.34M
Emmessar Biotech & Nutrition	135.69M
Vivanza Biosciences	84.00M
Norris Medicines	150.01M

Market Cap Rankings